SLC3A2 and acute myeloid leukemia: In NOD/SCID mice injected subcutaneously with the AML cell lines HL−60, OCI−AML−3, and KG−1, the anti-CD98 monoclonal antibody IGN523 reduced tumor growth by eliciting strong antibody−dependent cellular cytotoxicity (Hayes et al., 2015).